Reference data : LOINC code

Filter

Filter on:		In :	All (9) Loinc Number Component Property System Time aspect Long Common name Relat_nms MethodType ScaleType		Clear filter
AND
Filter on:		In :	All (9) Loinc Number Component Property System Time aspect Long Common name Relat_nms MethodType ScaleType
AND
Filter on:		In :	All (9) Loinc Number Component Property System Time aspect Long Common name Relat_nms MethodType ScaleType

Results

104,672 results found

• First page
• Previous page
• /4187
• Next page
• Last page

Loinc Number	Component	Property	System	Time aspect	ScaleType	MethodType	Relat_nms	loincStatus	Long Common name	answerList	chngType	DefinitionDescription	dtLastCh	exactCmspy	exampleUnits	exmplAnswers	externalCopyrightNotice	formula	hl7FieldSubfieldId	InpcPercentage	ipccUnits	loincClass	loincFinal	loincNum	mapTo	methodTyp	molarMass	naaccrId	orderObs	panelElements	reference	scope	setRoot	shortName	source	surveyQuestSrc	surveyQuestText	unitsRequired	acssym	relatedNames2	VersionLastChanged	VersionFirstRelease	ValidHL7AttachmentRequest	PanelType	AssociatedObservations	EXTERNAL_COPYRIGHT_LINK	HL7_ATTACHMENT_STRUCTURE	CONSUMER_NAME	EXAMPLE_UCUM_UNITS	STATUS_REASON	STATUS_TEXT	CHANGE_REASON_PUBLIC	COMMON_TEST_RANK	COMMON_ORDER_RANK
165-1	Cephapirin	Susc	Isolate	Pt	OrdQn	MIC		ACTIVE	Cephapirin [Susceptibility] by Minimum inhibitory concentration (MIC)		MIN	DefinitionDescription										ABXBACT		165-1		MIC			Observation				0	Cephapirin Islt MIC						ANTIBIOTIC SUSCEPTIBILITIES; AST; Cefadyl; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Minimum inhibitory concentration; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	2.19	1												0
1650-1	1,4-Alpha glucan branching enzyme	CCnc	WBC	Pt	Qn			ACTIVE	1,4-Alpha glucan branching enzyme [Enzymatic activity/volume] in Leukocytes		MIN	DefinitionDescription										CHEM		1650-1					Both				0	GLGB WBC-cCnc				Y		Alfa; Alpha-1,4-glucan branching enzyme; Catalytic Concentration; Chemistry; Enz; Enzymes; GLGB; Glycogen branching enzyme; i; Leukocytes; Point in time; Q-Enzyme; QNT; Quan; Quant; Quantitative; Random; WBCs; White blood cells	2.14	1												0
16500-1	Butyrate	MCnc	Stool	Pt	Qn			ACTIVE	Butyrate (C4) [Mass/volume] in Stool		MIN	DefinitionDescription										CHEM		16500-1					Observation				0	Butyrate Stl-mCnc				Y		Bowel movement; Butanoate; Butanoic acid; Butyric; Butyric acid; Chemistry; Faecal; Faeces; Fecal; Feces; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Stl; Stool = Fecal	2.34	1.0l												0
16501-9	C peptide^7th specimen post XXX challenge	MCnc	Ser/Plas	Pt	Qn			ACTIVE	C peptide [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge		MIN	DefinitionDescription			ng/mL							CHAL		16501-9					Observation				0	C peptide sp7 p chal SerPl-mCnc				Y		^7th spec pst XXX chal; After; CHEMISTRY.CHALLENGE TESTING; Connecting peptide of insulin; Level; Mass concentration; p chal; Pept; Pl; Plasma; Plsm; Point in time; Pro-insulin c peptide; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp7; sp7 p chal; Spec; SR	2.73	1.0l								ng/mL				0
16502-7	C peptide^8th specimen post XXX challenge	MCnc	Ser/Plas	Pt	Qn			ACTIVE	C peptide [Mass/volume] in Serum or Plasma --8th specimen post XXX challenge		MIN	DefinitionDescription			ng/mL							CHAL		16502-7					Observation				0	C peptide sp8 p chal SerPl-mCnc				Y		After; CHEMISTRY.CHALLENGE TESTING; Connecting peptide of insulin; Level; Mass concentration; p chal; Pept; Pl; Plasma; Plsm; Point in time; Pro-insulin c peptide; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp8; sp8 p chal; Spec; SR	2.34	1.0l								ng/mL				0
16503-5	C reactive protein	MCnc	Body fld	Pt	Qn			ACTIVE	C reactive protein [Mass/volume] in Body fluid		MIN	DefinitionDescription			ng/dL							CHEM		16503-5					Both				0	CRP Fld-mCnc				Y		B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Chemistry; CRP; Fl; Fld; FLU; Fluid; Level; Mass concentration; Point in time; PR; Prot; QNT; Quan; Quant; Quantitative; Random; Reac; React	2.73	1.0l								mg/dL				0
16504-3	Calcitonin^1.5M post XXX challenge	MCnc	Ser/Plas	Pt	Qn			ACTIVE	Calcitonin [Mass/volume] in Serum or Plasma --1.5 minutes post XXX challenge		MIN	DefinitionDescription			pg/mL							CHAL		16504-3					Observation				0	Calcit 1.5M p chal SerPl-mCnc				Y		1.5M p chal; After; CHEMISTRY.CHALLENGE TESTING; CT; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thyrocalcitonin; Tumor marker	2.34	1.0l								pg/mL				0
16505-0	Calcitonin^10M post XXX challenge	MCnc	Ser/Plas	Pt	Qn			ACTIVE	Calcitonin [Mass/volume] in Serum or Plasma --10 minutes post XXX challenge		MIN	DefinitionDescription			pg/mL							CHAL		16505-0					Observation				0	Calcit 10M p chal SerPl-mCnc				Y		10M p chal; After; CHEMISTRY.CHALLENGE TESTING; CT; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thyrocalcitonin; Tumor marker	2.34	1.0l								pg/mL				0
16506-8	Calcitonin^3H post XXX challenge	MCnc	Ser/Plas	Pt	Qn			ACTIVE	Calcitonin [Mass/volume] in Serum or Plasma --3 hours post XXX challenge		MIN	DefinitionDescription			pg/mL							CHAL		16506-8					Observation				0	Calcit 3h p chal SerPl-mCnc				Y		3h p chal; After; CHEMISTRY.CHALLENGE TESTING; CT; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thyrocalcitonin; Tumor marker	2.34	1.0l								pg/mL				0
16507-6	Calcitonin^4H post XXX challenge	MCnc	Ser/Plas	Pt	Qn			ACTIVE	Calcitonin [Mass/volume] in Serum or Plasma --4 hours post XXX challenge		MIN	DefinitionDescription			pg/mL							CHAL		16507-6					Observation				0	Calcit 4h p chal SerPl-mCnc				Y		4h p chal; After; CHEMISTRY.CHALLENGE TESTING; CT; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thyrocalcitonin; Tumor marker	2.34	1.0l								pg/mL				0
16508-4	Calcitonin^5M post XXX challenge	MCnc	Ser/Plas	Pt	Qn			ACTIVE	Calcitonin [Mass/volume] in Serum or Plasma --5 minutes post XXX challenge		MIN	DefinitionDescription			pg/mL							CHAL		16508-4					Observation				0	Calcit 5M p chal SerPl-mCnc				Y		5M p chal; After; CHEMISTRY.CHALLENGE TESTING; CT; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thyrocalcitonin; Tumor marker	2.34	1.0l								pg/mL				0
16509-2	Calcitonin^7th specimen post XXX challenge	MCnc	Ser/Plas	Pt	Qn			ACTIVE	Calcitonin [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge		MIN	DefinitionDescription			pg/mL							CHAL		16509-2					Observation				0	Calcit sp7 p chal SerPl-mCnc				Y		^7th spec pst XXX chal; After; CHEMISTRY.CHALLENGE TESTING; CT; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp7; sp7 p chal; Spec; SR; Thyrocalcitonin; Tumor marker	2.34	1.0l								pg/mL				0
1651-9	1-Methylhistidine	PrThr	Ser/Plas	Pt	Ord			ACTIVE	1-Methylhistidine [Presence] in Serum or Plasma		MIN	DefinitionDescription										CHEM		1651-9					Observation				0	1Me-hist SerPl Ql						1Me-hist; Chemistry; i; methyl-histidine; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	2.56	1											The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016.	0
16510-0	Calcitonin^8th specimen post XXX challenge	MCnc	Ser/Plas	Pt	Qn			ACTIVE	Calcitonin [Mass/volume] in Serum or Plasma --8th specimen post XXX challenge		MIN	DefinitionDescription			pg/mL							CHAL		16510-0					Observation				0	Calcit sp8 p chal SerPl-mCnc				Y		After; CHEMISTRY.CHALLENGE TESTING; CT; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp8; sp8 p chal; Spec; SR; Thyrocalcitonin; Tumor marker	2.34	1.0l								pg/mL				0
16511-8	Calcitonin^9th specimen post XXX challenge	MCnc	Ser/Plas	Pt	Qn			ACTIVE	Calcitonin [Mass/volume] in Serum or Plasma --9th specimen post XXX challenge		MIN	DefinitionDescription			pg/mL							CHAL		16511-8					Observation				0	Calcit sp9 p chal SerPl-mCnc				Y		After; CHEMISTRY.CHALLENGE TESTING; CT; Level; Mass concentration; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp9; sp9 p chal; Spec; SR; Thyrocalcitonin; Tumor marker	2.34	1.0l								pg/mL				0
16512-6	Calcium.ionized^2nd specimen post XXX challenge	SCnc	Ser/Plas	Pt	Qn			ACTIVE	Calcium.ionized [Moles/volume] in Serum or Plasma --2nd specimen post XXX challenge		MIN	DefinitionDescription			mmol/L							CHAL		16512-6					Observation				0	Ca-I sp2 p chal SerPl-sCnc				Y		After; Ca; Ca-I; Cal; Calcium active; Calcium free; CHEMISTRY.CHALLENGE TESTING; Coagulation factor I; Convalescent; ICA; Ion; Level; p chal; Pl; Plasma; Plsm; Point in time; Post immunization; PST; QNT; Quan; Quant; Quantitative; Random; Second; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp2; sp2 p chal; Spec; SR; Substance concentration	2.34	1.0l								mmol/L				0
16513-4	Calcium.ionized^3rd specimen post XXX challenge	SCnc	Ser/Plas	Pt	Qn			ACTIVE	Calcium.ionized [Moles/volume] in Serum or Plasma --3rd specimen post XXX challenge		MIN	DefinitionDescription			mmol/L							CHAL		16513-4					Observation				0	Ca-I sp3 p chal SerPl-sCnc				Y		After; Ca; Ca-I; Cal; Calcium active; Calcium free; CHEMISTRY.CHALLENGE TESTING; Coagulation factor I; ICA; Ion; Level; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp3; sp3 p chal; Spec; SR; Substance concentration	2.34	1.0l								mmol/L				0
16514-2	Calcium.ionized^4th specimen post XXX challenge	SCnc	Ser/Plas	Pt	Qn			ACTIVE	Calcium.ionized [Moles/volume] in Serum or Plasma --4th specimen post XXX challenge		MIN	DefinitionDescription			mmol/L							CHAL		16514-2					Observation				0	Ca-I sp4 p chal SerPl-sCnc				Y		After; Ca; Ca-I; Cal; Calcium active; Calcium free; CHEMISTRY.CHALLENGE TESTING; Coagulation factor I; ICA; Ion; Level; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp4; sp4 p chal; Spec; SR; Substance concentration	2.34	1.0l								mmol/L				0
16515-9	Calcium.ionized^5th specimen post XXX challenge	SCnc	Ser/Plas	Pt	Qn			ACTIVE	Calcium.ionized [Moles/volume] in Serum or Plasma --5th specimen post XXX challenge		MIN	DefinitionDescription			mmol/L							CHAL		16515-9					Observation				0	Ca-I sp5 p chal SerPl-sCnc				Y		After; Ca; Ca-I; Cal; Calcium active; Calcium free; CHEMISTRY.CHALLENGE TESTING; Coagulation factor I; ICA; Ion; Level; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp5; sp5 p chal; Spec; SR; Substance concentration	2.34	1.0l								mmol/L				0
16516-7	Calcium.ionized^6th specimen post XXX challenge	SCnc	Ser/Plas	Pt	Qn			ACTIVE	Calcium.ionized [Moles/volume] in Serum or Plasma --6th specimen post XXX challenge		MIN	DefinitionDescription			mmol/L							CHAL		16516-7					Observation				0	Ca-I sp6 p chal SerPl-sCnc				Y		After; Ca; Ca-I; Cal; Calcium active; Calcium free; CHEMISTRY.CHALLENGE TESTING; Coagulation factor I; ICA; Ion; Level; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp6; sp6 p chal; Spec; SR; Substance concentration	2.34	1.0l								mmol/L				0
16517-5	Calcium.ionized^7th specimen post XXX challenge	SCnc	Ser/Plas	Pt	Qn			ACTIVE	Calcium.ionized [Moles/volume] in Serum or Plasma --7th specimen post XXX challenge		MIN	DefinitionDescription			mmol/L							CHAL		16517-5					Observation				0	Ca-I sp7 p chal SerPl-sCnc				Y		^7th spec pst XXX chal; After; Ca; Ca-I; Cal; Calcium active; Calcium free; CHEMISTRY.CHALLENGE TESTING; Coagulation factor I; ICA; Ion; Level; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; sp7; sp7 p chal; Spec; SR; Substance concentration	2.34	1.0l								mmol/L				0
16518-3	Calcium	MRat	Urine	2H	Qn			ACTIVE	Calcium [Mass/time] in 2 hour Urine		MIN	DefinitionDescription			mg/2 H							CHEM		16518-3					Both				0	Calcium 2h Ur-mRate				Y		120 min; 120 minutes; 120min; 2 hours; 2HR; Ca; Cal; Chemistry; Mass Rate; mRate; QNT; Quan; Quant; Quantitative; UA; UR; Urn	2.73	1.0l								mg/(2.h)				0
16519-1	Calcium^10M post XXX challenge	SCnc	Ser/Plas	Pt	Qn			ACTIVE	Calcium [Moles/volume] in Serum or Plasma --10 minutes post XXX challenge		MIN	DefinitionDescription			mmol/L							CHAL		16519-1					Observation				0	Calcium 10M p chal SerPl-sCnc				Y		10M p chal; After; Ca; Cal; CHEMISTRY.CHALLENGE TESTING; Level; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	2.34	1.0l								mmol/L				0
1652-7	1-Methylhistidine	MCnc	Ser/Plas	Pt	Qn			ACTIVE	1-Methylhistidine [Mass/volume] in Serum or Plasma		MIN	DefinitionDescription			mg/dL							CHEM		1652-7					Observation				0	1Me-hist SerPl-mCnc				Y		1Me-hist; Chemistry; i; Level; Mass concentration; methyl-histidine; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	2.73	1								mg/dL				0
16520-9	Calcium^2nd specimen post XXX challenge	SCnc	Urine	Pt	Qn			ACTIVE	Calcium [Moles/volume] in Urine --2nd specimen post XXX challenge		MIN	DefinitionDescription			mmol/L							CHAL		16520-9					Observation				0	Calcium sp2 p chal Ur-sCnc				Y		After; Ca; Cal; CHEMISTRY.CHALLENGE TESTING; Convalescent; Level; p chal; Point in time; Post immunization; PST; QNT; Quan; Quant; Quantitative; Random; Second; sp2; sp2 p chal; Spec; Substance concentration; UA; UR; Urn	2.34	1.0l								mmol/L				0

104,672 results found

• First page
• Previous page
• /4187
• Next page
• Last page